FDA Archives - MLMIC Insurance Company

Apr 13, 2020

New Research Highlights Concerns Related to Use of Chloroquine, Hydroxychloroquine and Azithromycin for Treating COVID-19 Patients

New research indicates there is weak evidence that chloroquine, hydroxychloroquine and azithromycin can effectively treat and prevent COVID-19 and the drugs carry potentially serious risks.

Posted in: Hospitals, Physicians

Tagged with: coronavirus, covid-19, FDA, medications, patient care, patient safety, risk management

Apr 1, 2020

When Appropriate, FDA Permits Use of Hydroxychloroquine and Chloroquine to Treat COVID-19

The FDA issued emergency use authorization for anti-malarial drugs hydroxychloroquine and chloroquine to treat COVID-19 patients when deemed appropriate by a healthcare provider.

Posted in: Hospitals, Physicians

Tagged with: coronavirus, covid-19, FDA, healthcare law, medications, patient care, risk management

Oct 8, 2019

FDA Releases Guidelines on Regulation of Medical Software

The FDA has updated guidance on which medical devices are regulated by the agency.

Posted in: Hospitals, Physicians

Tagged with: advisory, FDA, healthcare IT, medical devices, patient safety, reduce risk

Oct 3, 2019

FDA Issues Warning About Serious Security Flaws in Critical Medical Devices

The FDA warns manufacturers, healthcare providers, hospitals and patients that the “URGENT/11” security flaws may cause medical devices to malfunction.

Posted in: Hospitals, Physicians

Tagged with: advisory, FDA, healthcare IT, medical devices, patient safety, reduce risk